Sotabase

Career

· Research Assistant, Berkeley AI Research Laboratory2023–
· Software Engineering Consultant, Meditrina Inc.2022–
· Charles Reiss - PhD Candidate in Computer Science, UC Berkeley2016–

Publications (0)

Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose
2002
162
cited
Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D
The Lancet · 1995
158
cited
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
European Journal of Surgical Oncology · 2007
124
cited
Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients.
British Journal of Cancer · 1998
121
cited
Comparison of a 6‐month course peginterferon α‐2b plus ribavirin and interferon α‐2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan
Journal of Viral Hepatitis · 2005
82
cited
The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan.
Journal of Infectious Diseases · 1982
78
cited
The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Digestive and Liver Disease · 2008
55
cited
Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long‐term outcome
Alimentary Pharmacology and Therapeutics · 2004
45
cited
C‐reactive protein and lactate dehydrogenase isoenzymes in the assessment of the prognosis of acute pancreatitis
Journal of Gastroenterology and Hepatology · 1992
45
cited
Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Clinical Radiology · 2012
45
cited
Hepatitis C virus infection‐related Type 1 diabetes mellitus
Diabetic Medicine · 2005
42
cited
Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen‐negative chronic hepatitis B patients in Taiwan
Journal of Viral Hepatitis · 2003
41
cited
Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study.
Annals of Oncology · 2003
33
cited
The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage
Alimentary Pharmacology and Therapeutics · 2005
33
cited
Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C.
Tissue Antigens · 2002
32
cited
Association of core promoter/precore mutations and viral load in e antigen‐negative chronic hepatitis B patients
Journal of Viral Hepatitis · 2006
29
cited
Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study.
Annals of Oncology · 2004
23
cited
Hypercholesterolaemia in patients with hepatocellular carcinoma
Journal of Gastroenterology and Hepatology · 1992
22
cited
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: A short‐term, randomized, double‐blind controlled, cross‐over study with long‐term follow up
Journal of Gastroenterology and Hepatology · 1993
22
cited
Long‐term evaluation of recombinant interferon α2b in the treatment of patients with hepatitis B e antigen‐negative chronic hepatitis B in Taiwan
Journal of Viral Hepatitis · 2001
20
cited
Sotabase